Introduction {#s1}
============

In 2015, five prospective, randomized trials confirmed the superiority of endovascular thrombectomy over medical management for the treatment of acute ischemic stroke.[@R1] Recently, a survey of neurointerventionalists reported the most common first-line mechanical thrombectomy approach to be the direct aspiration first-pass (ADAPT) technique.[@R6] This approach involves the removal of clot via an aspiration catheter connected to an external suction source. The availability of effective suction to the middle cerebral arteries (MCA) and beyond during ADAPT is challenging to ensure, and essential to, the successful removal of thrombus. While advances in aspiration catheter performance have been associated with faster procedure times, higher recannulation rates and better outcomes,[@R7] failure to recanalize with currently available aspiration catheters occurs in approximately one-third of patients.[@R15]

Based on current data, it is possible that larger suction aspiration catheters are correlated with improved recanalization.[@R11] Catheters with tapered, large bore designs have been introduced to harness the benefits of an increased tip surface area. Alternatively, a new catheter design effectively increases inner diameter for the entire system. We sought to evaluate these new suction catheters, all compatible with standard guiding catheters, that would retain, or even improve on, the navigability of current suction catheters yet profoundly increase the suction efficiency based on larger inner diameters.

Methods {#s2}
=======

Catheter design {#s2a}
---------------

Due to neurovascular vessel size constraints, the design of an effective aspiration catheter often involves a tradeoff between suction strength and ability to access the distal neurovasculature. While improved suction power has been associated with larger diameter catheters,[@R18] thrombi are often located in highly tortuous, small diameter vessels. As a compromise, the implementation of a tapered design is common. The distal tip of the aspiration catheter is smaller than the proximal shaft, maximizing both suction capability and distal access. This design approach is ultimately limited by the inner diameter (ID) of the required guide catheter and the minimum wall thickness of the aspiration catheter. The R^4^Q aspiration catheter (MIVI Neuroscience, Inc., Eden Prairie, MN) design overcomes these limitations by eliminating the proximal three-quarters of the catheter shaft and replacing it with a 117 cm, 0.018 inch stainless steel control wire. This enables the utilization of the full internal area of the guide catheter for the delivery of suction power ([figure 1](#F1){ref-type="fig"}). A R^4^Q family has an outer diameter (OD) along the proximal catheter segments of 0.088 inch, with distal ODs of 0.082 inch, 0.072 inch, 0.055 inch, and 0.048 inch and named as R^4^Q 6F, 5F, 4F, and 3F, respectively. Similar to standard aspiration catheter designs, the R^4^Q is delivered to the clot site via a micro-wire and micro-catheter within an 8F guide catheter/6F sheath. Unlike standard designs, suction is applied directly to the guide catheter and the total system length is variable as the R^4^Q is extended outward and retracted into the guide catheter.

![Conceptual schematic of the R^4^Q friction fit into distal end of the guide catheter compared with the standard aspiration catheter system. The control wire (solid black) occupies less volume than the standard catheter within the guide catheter. Note: dimensions are not to scale.](neurintsurg-2017-013702f01){#F1}

The R^4^Q was designed to maximize flow and minimize pressure loss. In fluid dynamics, all primary relationships are defined by a set of fundamental equations called the Navier--Stokes Equations. These equations further simplify to relate fluid properties (viscosity), channel geometry (length and ID), and hydraulic characteristics (flow rate and pressure loss) in an equation known as the Hagen--Poiseuille Law (HPL). This relationship applies to nonaccelerating fluid in a tube of consistent diameter.[@R23]

Hagen--Poiseuille Law

$$Q = \frac{\pi r^{4}\Delta P}{8\eta L}$$

where Q=volumetric flow rate, π= constant pi, r=inner radius, Δ*P*= pressure drop, η=liquid viscosity, and L=length of tube.

Improvement of thrombus aspiration requires increased flow-derived vacuum to achieve greater suction transmission through the catheter. According to the HPL, the variable leveraging the greatest effect on flow-derived vacuum is the mean ID of the device. Since even a small increase in ID results in significant increases in flow rate, the R^4^Q was designed to achieve aspiration rates and forces greater than standard catheter designs. Prior scientific examination has similarly established the powerful relationship of ID to pressure loss and flow rate in small vessels.[@R18] We sought to compare these factors in the R^4^Q and other catheters in vitro.

Vacuum flow rate {#s2b}
----------------

To empirically examine the performance of this novel design, we tested all sizes of the R^4^Q against 10 commercially available catheters ([table 1](#T1){ref-type="table"}). A representative effective ID was calculated for each catheter using the corresponding proportion of the distal and proximal IDs to account for the non-uniform IDs. The R^4^Qs' distal IDs refer to the distal portion of the system, while the proximal IDs correspond to the guiding catheter used in the system. Other tapered catheters' effective IDs were approximated with a 10% distal ID, 90% proximal ID proportion of the working length. The effective IDs are listed in [table 1](#T1){ref-type="table"} for reference. Following a method previously described by Hu and Stiefel ([figure 2A](#F2){ref-type="fig"}),[@R26] a Gomco aspiration pump Model 4005 P (Allied Healthcare Products, St. Louis, MO) was set to deliver 600 mmHg of vacuum through 2.794 mm (0.110 inch) ID aspiration tubing (MIVI Neuroscience, Inc.) with a standard in-line valve and lure fittings. The R^4^Q was used in combination with a Super 90 guide catheter 8F (MIVI Neuroscience, Inc.), which has an ID of 0.090 inch, OD of 0.114 inch, and length of 90 cm. When the vacuum pressure attained a steady state, the valve was released allowing room-temperature water to be aspirated by the catheter into the pump collection canister. An electronic switch shut off the pump after 110 s, and the aspirated fluid was weighed. Standard values for water density were used to calculate the mean volumetric flow rate through the catheter by dividing aspirated fluid weight by time. This process was repeated three times and averaged for each catheter tested. The SD for each sample population never exceeded 1% of the measured average.

![Schematic of experimental setup for vacuum flow rate (A) and tip force measurements (B).](neurintsurg-2017-013702f02){#F2}

###### 

Catheters

  Outer diameter       Catheter                  Company                   Distal ID (in)   Proximal ID (in)   Distal area (in^2^)   Length of tube (cm)   Effective ID (in)
  -------------------- ------------------------- ------------------------- ---------------- ------------------ --------------------- --------------------- -------------------
  6F                   R^4^Q 6F                  MIVI Neuroscience, Inc.   0.069            0.090\*            0.0037                115                   0.0854
  *Eden Prairie, MN*                                                                                                                                       
  Sophia Plus          MicroVention Terumo       0.07                      0.07             0.0038             131                   0.0700                
  *Tustin, CA*                                                                                                                                             
  ACE 68               Penumbra                  0.068                     0.068            0.0036             132                   0.0680                
  *Alameda, CA*                                                                                                                                            
  ACE 064              Penumbra                  0.064                     0.068            0.0032             132                   0.0672                
  *Alameda, CA*                                                                                                                                            
  5F                   R^4^Q 5F                  MIVI Neuroscience, Inc.   0.057            0.090\*            0.0026                115                   0.0828
  *Eden Prairie, MN*                                                                                                                                       
  ARC                  Medtronic                 0.061                     0.069            0.0029             132                   0.0682                
  *Minneapolis, MN*                                                                                                                                        
  Mi-Axus 6            MIVI Neuroscience, Inc.   0.057                     0.064            0.0026             128                   0.0633                
  *Eden Prairie, MN*                                                                                                                                       
  InNeuroCo            Codman Neuro              0.06                      0.064            0.0028             125                   0.0636                
  *Raynham, MA*                                                                                                                                            
  5MAX ACE             Penumbra                  0.056                     0.064            0.0028             132                   0.0636                
  *Alameda, CA*                                                                                                                                            
  5MAX                 Penumbra                  0.054                     0.064            0.0023             128                   0.0630                
  *Alameda, CA*                                                                                                                                            
  4F                   R^4^Q 4F                  MIVI Neuroscience, Inc.   0.043            0.090\*            0.0015                120                   0.0778
  *Eden Prairie, MN*                                                                                                                                       
  4MAX                 Penumbra                  0.041                     0.064            0.0013             139                   0.0617                
  *Alameda, CA*                                                                                                                                            
  3F                   R^4^Q 3F                  MIVI Neuroscience, Inc.   0.036            0.090\*            0.00102               125                   0.0768
  *Eden Prairie, MN*                                                                                                                                       
  3MAX                 Penumbra                  0.035                     0.043            0.00096            153                   0.0422                
  *Alameda, CA*                                                                                                                                            

\*Guide catheter ID is used as the proximal ID dimension of the R^4^Q system.

Since the R^4^Q catheter is not one continuous tube throughout its length, this introduces the possibility of liquid entering the system at the junction between the R^4^Q shaft and the guide catheter. To observe this phenomenon, the catheter tip was obstructed with a ga pin and the flow rate was measured with the R^4^Q and guide catheter junction submerged in open water. This flow rate, 4.9 mL/min, calculates to 1.52% of the aspirated volume when the catheter tip is fully patent. Therefore, to account for a worst-case scenario in which all vacuum pressure is focused on the junction, we decreased the R^4^Q flow rates by 1.52%.

Tip force {#s2c}
---------

In addition to dynamic flow rate, the force at the catheter tip was measured by simulating a corked tip condition. The setup is depicted in [figure 2B](#F2){ref-type="fig"}. A 0.068 inch pin ga was inserted in the distal tip to create a nearly obstructed flow path after the system was flooded with room temperature tap water. The pin gauge was attached via a hemostasis valve to a digital force gauge (Ametek Chatillon, Berwyn, PA, USA) and aligned with the aspiration catheter tip. The junction between the R^4^Q and guide catheter was submerged in a fluid-filled closed tube to control the pressure and isolate the force measurement at the tip. Aspiration was applied to the guide catheter using the setup previously described and adjusted to 600 mmHg of vacuum. The force gauge and pin gage were pulled from the tip and the maximum gram force was recorded. The R^4^Q was used with a Super 90 guide catheter 8F and compared head-to-head with a Penumbra ACE 68 in the identical setup with aspiration directly connected to the ACE 68. For both catheters, the forces were also measured in the same configuration without aspiration to determine the force due to friction between the pin gage and the catheter tip. These forces were averaged and subtracted from measurements with aspiration to find the force attributed to aspiration in the catheter.

Impact of retraction on flow rate {#s2d}
---------------------------------

As the nozzle tip of the R^4^Q system is withdrawn into the guide catheter, the overall length of the fluid path decreases. The effects of these factors positively contribute to flow rate (Q) in the HPL. In order to quantify this phenomenon, flow rate was measured as the R^4^Q was retracted within an 8F guide catheter. The flow rate was measured at full extension from the guide catheter. The R^4^Q was then retracted in 5 cm increments until it was fully inside the guide catheter. Flow rates were measured in five repetitions at each retraction point. The same procedure was performed with a similarly sized standard catheter.

Statistics {#s2e}
----------

In the flow rate experimental setup, only three repetitions were necessary for each catheter tested due to low variability. All tests were performed with consistent experimental conditions in an attempt to limit confounding variables. An additional sequence of 10 flow tests was completed on the R^4^Q 6F and ACE 68 to confirm the validity of the results.

Results {#s3}
=======

Vacuum flow rate {#s3a}
----------------

[Table 2](#T2){ref-type="table"} and [figure 3A](#F3){ref-type="fig"} summarize the flow rate collected by this method. The R^4^Q exhibited higher flow rates than other commercially available catheters tested.

###### 

Flow rates

  Catheter       Flow rate (mL/s)
  -------------- ------------------
  R^4^Q 6F       5.31
  Sophia plus    4.42
  ACE 068        4.27
  ACE 064        4.36
  R^4^Q 5F       4.93
  ARC            4.01
  Mi-Axus 6      3.82
  InNeuroCo 6F   3.48
  5MAX ACE       3.60
  5MAX           3.00
  R^4^Q 4F       3.89
  4MAX           2.44
  R4Q 3F         3.50
  3MAX           1.03

![(A) Catheter flow rates by outer diameter size. (B) Average gram force measured for the ACE 68 and the R^4^Q.](neurintsurg-2017-013702f03){#F3}

Tip force {#s3b}
---------

[Figure 3B](#F3){ref-type="fig"} portrays average force for each catheter, corrected for friction. Forces attributed to friction as measured with no aspiration for the R^4^Q and ACE 68 were 19.9 and 17.4 gram force respectively. The R^4^Q forces were more variable between trials but had a significantly higher average compared with the ACE 68 (Student T-Test, P\<0.0001).

Impact of retraction on flow rate {#s3c}
---------------------------------

The R^4^Q system benefits from its dynamic length. The R^4^Q exhibits significantly greater suction force at the tip than the other devices tested despite a similar distal ID and surface area. Furthermore, once the R^4^Q is retracted completely into the guide catheter, the cross-sectional area presented to the clot is significantly increased, leading to even greater suction. When the R^4^Q 6F is extended 25 cm out of the guide catheter, it exhibited a 39% increase in flow rate over the standard catheter ([figure 4](#F4){ref-type="fig"}). At full retraction, the flow rate of the R^4^Q 6F was 117.2% greater. Since the length of a standard catheter remains constant during aspiration use, the flow rate does not change.

![R^4^Q 6F flow rate (solid line) at multiple positions inside an 8F guide catheter compared with the constant flow rate of a similarly sized uniform catheter (dashed line).](neurintsurg-2017-013702f04){#F4}

Data reproducibility {#s3d}
--------------------

An additional sequence of 10 flow tests per catheter was completed to confirm the validity of the results. This replication portrays the precision of the entire experimental design. A two-sample T-test conducted with JMP Pro 13 software presented a significant difference between the flow rates of the R^4^Q 6F and a uniformly sized catheter, the ACE 68 (n=10 for each device, P\<0.0001). The SD for the R^4^Q 6F and the ACE 68 were 0.0544 mL/s and 0.0751 mL/s respectively, accounting for 0.98% and 1.59% of the average flow rate values.

Discussion {#s4}
==========

In the current study we demonstrated profound increases in flow rate and tip force in the R^4^Q catheter compared with standard suction catheters. These increases were correlated with the effective diameter of the R^4^Q, which harnesses the large ID of the guide catheter to improve suction. In effect, the R^4^Q achieves markedly improved performance without the need for larger ID catheters. Notably, percent increases in flow rate were greatest in the smallest diameter system comparisons, offering the promise of improved suction embolectomy in narrow, distal branches. Finally, we demonstrated that suction forces increase when the tip of the R^4^Q is retracted through the guide, which will likely diminish the risk of distal emboli migration caused by lack of adherence to the catheter tip. Taken together, these findings illuminate the differences between the R^4^Q's alternative design and classic suction catheters. Unlike standard catheters, the R^4^Q system optimizes the guide catheter ID at the proximal end of the system. In addition, the ability of the R^4^Q system to shorten during use further improves aspiration rate and force. These properties have the potential to translate into clinical advances in aspiration thrombectomy.

Prior in vitro studies of aspiration catheter flow have shown that larger ID catheters exhibit higher flow rates and tip forces due to greater surface area at the tip[@R26] and catheter diameter has a correlation with thrombectomy success in coronary aspiration thrombectomy to treat acute myocardial infarction.[@R29] Catheters providing high flow rates to dynamically pull the clot into the catheter tip and greater tip force to keep the clot suctioned to the tip may be more successful clinically.[@R8] These studies have focused on tip characteristics while we have emphasized the importance of the overall system dimensions. Significant increases in aspiration force observed in the R^4^Q present minimal additional procedural risk in preclinical observations. Furthermore, aspiration thrombectomy in general results in less damage to vessel vasculature than stent retriever thrombectomy.[@R31]

This study is limited by the mathematical assumptions of the HPL, namely that flow of Newtonian fluid is laminar and nonaccelerating through a circular tube significantly longer than its diameter. It is important to note that the HPL is ideal for a tube of constant circular cross-section. Although some of the catheters in this study do not have constant IDs, the HPL is used as an approximation for the physical relationships observed. The highly tortuous nature of neurovascular anatomy undoubtedly affects fluid flow dynamics and should be investigated further. It is also important to note that fluidic properties of water are similar but not identical to human blood. Blood is more viscous than water and is classified as a non-Newtonian fluid. However, we found that while flow results for one catheter differ between water and glycerol, the comparative relationship across catheters does not vary significantly. Nonetheless, these in vitro results are approximations and should be supplemented with clinical assessment.

In addition, the tip force measured here does not represent a fully sealed catheter tip but rather it mimics a more realistic corking scenario in which the clot does not completely seal the tip interface. Previous work has revealed that catheters of varying diameters relay similar vacuum pressures but the theoretical amount of suction force relies on the area via F=P\*A where P is vacuum pressure and A is catheter area.[@R27] While this relationship applies to closed, static catheter systems, if there is any fluid or air moving through the system, more complicated physics apply. If the clot does fully obstruct the catheter tip from fluid and air, the clot itself shares properties of a highly viscous liquid and obeys dynamic fluid laws. Additionally, the measured flow rate increases as the system length decreased by retracting the R^4^Q into the guide catheter. This cannot be explained by the pressure-derived force since the area remains constant as the R^4^Q is retracted. Therefore, we hypothesize that the force at the tip is also dictated by the HPL.

By leveraging established theory in fluid mechanics, the R^4^Q aspiration can deliver superior suction to many areas of the neurovasculature, even distal regions of the MCA. With this device, the complexity and time required for a successful mechanical thrombectomy are expected to decrease significantly, resulting in more effective procedures and improved patient outcome. Future work will assess the performance of the catheter in a clinical study.
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